> Products > L-Lysine

China L-Lysine Factory

With our excellent management, strong technical capability and strict quality control system, we continue to provide our clients with reliable quality, reasonable prices and excellent services. We aim at becoming one of your most reliable partners and earning your satisfaction for L-Lysine,CAS NO 57282-49-2,57282-49-2,L-Lysine API, Welcome your browsing and any your inquires,sincerely hope we are able to have chance to cooperate with you and we will build-up extensive effectively company marriage along with you.
L-Lysine, Our company is working by the operation principle of "integrity-based, cooperation created, people oriented, win-win cooperation". We hope we can have a friendly relationship with businessman from all over the world.

Hot Products

Butyl chloroformate
Product Name:Butyl chloroformate
Molecular Formula:C5H9ClO2
Molecular Weight:136.58
CAS Registry Number;592-34-7
N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid 1,5-diethyl ester 4-methylbenzenesulfonate
Product Name:N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid 1,5-diethyl ester 4-methylbenzenesulfonate
Molecular Formula:C31H37N5O9S
Molecular Weight:655.72
CAS Registry Number:165049-28-5
2,3-Difluorobenzyl alcohol
Product Name:2,3-Difluorobenzyl alcohol
Molecular Formula:C7H6F2O
Molecular Weight:144.12
CAS Registry Number:75853-18-8
Ezetimibe
Product Name:Ezetimibe
Molecular Formula:C24H21F2NO3
Molecular Weight;409.43
CAS Registry Number;163222-33-1
(2S)-2-Amino-4-methyl-1-((2R)-2-methyloxiranyl)-1-pentanone trifluoroacetate
Product Name:(2S)-2-Amino-4-methyl-1-((2R)-2-methyloxiranyl)-1-pentanone trifluoroacetate
Molecular Formula:C9H17NO2.C2HF3O2
Molecular Weight:285.26
CAS Registry Number:247068-85-5
MonoMethyl auristatin F
Product Name:MonoMethyl auristatin F
Molecular Formula:C39H65N5O8
Molecular Weight;731.96
CAS Registry Number;745017-94-1

Related Blog
Reviews

Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry
Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.
Development Trend of China's Pharmaceutical Intermediate Industry
The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.
Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?
API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.
Why API manufacturing companies almostly in China?
In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...
FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC
On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.
Bosutinib CAS 380843-75-4
Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

Related Search

L-Lysine API N6-Cbz-L-Lysine

China L-Lysine Factory

Related Products

Hot Products

Butyl chloroformate

N-[4-[2-(2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid 1,5-diethyl ester 4-methylbenzenesulfonate

2,3-Difluorobenzyl alcohol

Ezetimibe

(2S)-2-Amino-4-methyl-1-((2R)-2-methyloxiranyl)-1-pentanone trifluoroacetate

MonoMethyl auristatin F

Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

Development Trend of China's Pharmaceutical Intermediate Industry

Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

Why API manufacturing companies almostly in China?

FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

Bosutinib CAS 380843-75-4

Alexandra 2022-04-05 23:38:53

Sandy 2022-12-19 23:23:29

Louis 2022-11-05 22:49:51

Kelly 2022-08-31 04:25:14

Joanne 2022-11-20 06:16:15

Tom 2024-05-05 06:13:55

Related Search

Send Inquiry